Lexicon pharmaceuticals incorporated LXRX.US Whale Interest Analysis
US StockHealth Care
(No presentation for LXRX)
LXRX Whale Interest Score
3
24
15
Slight Interest
- AI analysis rates LXRX with a lower whale interest score of 2.
- The significant concentrated ownership comes with higher risks in stock performance.
- Institutions have been consistently buying for 3 consecutive quarters, indicating ongoing strategic positioning.
- Tracking 10 prominent institutions, the following have traded this quarter:
- Buying: Renaissance Technologies LLC
- Selling: None
LXRX Whale Interest Reference Factors
According to the latest 13F reports, we summarizes key information, including whale invest rate, number of institutions, and related fund flows, providing an overview of major institutional activity.
Update to 2025/2/18 (Quarterly Update)
Net Flow (Inflow - Outflow)$10.33M
Capital Inflow
$32.61M
Accumulator : 49 $29.07M
Initiator : 26 $3.54M
Capital Outflow
$22.28M
Reducer : 29 $2.26M
Liquidator : 37 $20.02M
LXRX Historical Whale Interest Score
You can use historical scores of 3 or above to observe potential performance and make investment decisions.
Prominent Inst. Holdings of LXRX
The buying and selling records of 10 well-known and widely followed institutions for this stock over the past year are listed in the table below.
2024Q4Shares
51.14 KNew Buy
2024Q3Shares
--
2024Q2Shares
--
2024Q1Shares
-Sold Out
LXRX Insider Transactions
In the past year, LXRX has not engaged in insider trading of stocks.

No related data records